{"id":16863,"date":"2016-10-21T11:10:00","date_gmt":"2016-10-21T09:10:00","guid":{"rendered":"http:\/\/mabdesign.fr\/astrazeneca-backs-adc-in-e96m\/"},"modified":"2024-12-16T16:18:15","modified_gmt":"2024-12-16T15:18:15","slug":"astrazeneca-backs-adc-in-e96m","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/","title":{"rendered":"AstraZeneca backs ADC in \u20ac96M"},"content":{"rendered":"<p style=\"text-align: justify;\">Labiotech.eu &#8211; 19\/10\/2016<\/p>\n<p style=\"text-align: justify;\"><strong>ADC Therapeutics (ADCT)<\/strong> is a Swiss Biotech that develops <strong>antibody-drug conjugates (ADCs)<\/strong> for oncology applications. Its founder <strong>Auven Therapeutics<\/strong>\u00a0and its partner <strong>AstraZeneca<\/strong> have participated in the <strong>biggest funding\u00a0round<\/strong> of the year in Europe: a whopping\u00a0<strong>\u20ac96M<\/strong>.<\/p>\n<p>ADCT plans to use the funds to advance nothing less than <strong>6 clinical programs<\/strong> in the next <strong>18 months<\/strong>. Two of their candidates, <strong>ADCT-301<\/strong> and <strong>ADCT-402<\/strong>, are already in <strong>Phase Ia<\/strong>. Both are being tested to treat <a href=\"http:\/\/labiotech.eu\/blood-cancer-day-biotech-fixing\/\">sub-types of <strong>lymphoma and leukemia<\/strong><\/a>.<\/p>\n<p><a href=\"http:\/\/labiotech.eu\/adc-therapeutics-highest-funding-round-europe-antibody-drug-conjugates\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #6aa336;\">READ MORE<\/span><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AstraZeneca has contributed to ADC Therapeutics\u2019 \u20ac96M fundraising, the biggest round so far in Europe this year.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-16863","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AstraZeneca backs ADC in \u20ac96M - MabDesign<\/title>\n<meta name=\"description\" content=\"AstraZeneca has contributed to ADC Therapeutics\u2019 \u20ac96M fundraising, the biggest round so far in Europe this year.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca backs ADC in \u20ac96M - MabDesign\" \/>\n<meta property=\"og:description\" content=\"AstraZeneca has contributed to ADC Therapeutics\u2019 \u20ac96M fundraising, the biggest round so far in Europe this year.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2016-10-21T09:10:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-16T15:18:15+00:00\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"AstraZeneca backs ADC in \u20ac96M\",\"datePublished\":\"2016-10-21T09:10:00+00:00\",\"dateModified\":\"2024-12-16T15:18:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/\"},\"wordCount\":89,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/\",\"name\":\"AstraZeneca backs ADC in \u20ac96M - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"datePublished\":\"2016-10-21T09:10:00+00:00\",\"dateModified\":\"2024-12-16T15:18:15+00:00\",\"description\":\"AstraZeneca has contributed to ADC Therapeutics\u2019 \u20ac96M fundraising, the biggest round so far in Europe this year.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AstraZeneca backs ADC in \u20ac96M\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AstraZeneca backs ADC in \u20ac96M - MabDesign","description":"AstraZeneca has contributed to ADC Therapeutics\u2019 \u20ac96M fundraising, the biggest round so far in Europe this year.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/","og_locale":"en_US","og_type":"article","og_title":"AstraZeneca backs ADC in \u20ac96M - MabDesign","og_description":"AstraZeneca has contributed to ADC Therapeutics\u2019 \u20ac96M fundraising, the biggest round so far in Europe this year.","og_url":"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/","og_site_name":"MabDesign","article_published_time":"2016-10-21T09:10:00+00:00","article_modified_time":"2024-12-16T15:18:15+00:00","author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"AstraZeneca backs ADC in \u20ac96M","datePublished":"2016-10-21T09:10:00+00:00","dateModified":"2024-12-16T15:18:15+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/"},"wordCount":89,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/","url":"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/","name":"AstraZeneca backs ADC in \u20ac96M - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"datePublished":"2016-10-21T09:10:00+00:00","dateModified":"2024-12-16T15:18:15+00:00","description":"AstraZeneca has contributed to ADC Therapeutics\u2019 \u20ac96M fundraising, the biggest round so far in Europe this year.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/astrazeneca-backs-adc-in-e96m\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca backs ADC in \u20ac96M"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=16863"}],"version-history":[{"count":1,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16863\/revisions"}],"predecessor-version":[{"id":26687,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16863\/revisions\/26687"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=16863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=16863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=16863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}